Behbahani Ali
Related Filers (21)
- Black Diamond Therapeutics, Inc. (17)
- Adaptimmune Therapeutics PLC (12)
- CRISPR Therapeutics AG (11)
- GENOCEA BIOSCIENCES, INC. (11)
- NEVRO CORP (9)
- Bright Health Group Inc. (8)
- Regulus Therapeutics Inc. (5)
- Nkarta, Inc. (5)
- CVRx, Inc. (5)
- Trevi Therapeutics, Inc. (5)
- Oyster Point Pharma, Inc. (5)
- Monte Rosa Therapeutics, Inc. (5)
- Arcellx, Inc. (4)
- Akouos, Inc. (3)
- Metacrine, Inc. (3)
- MINERVA SURGICAL INC (3)
- Mirum Pharmaceuticals, Inc. (3)
- Marker Therapeutics, Inc. (2)
- Savara Inc (2)
- Korro Bio, Inc. (2)
- Arsanis, Inc. (1)
- Show More ...
Ownership (121)
4
Wednesday, 1/17/2024
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Thursday, 12/21/2023
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/18/2023
CVRx, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/15/2023
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/7/2023
Korro Bio, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/7/2023
Korro Bio, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 11/2/2023
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/19/2023
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/18/2023
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/19/2023
Savara Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 7/6/2023
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/3/2023
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
Arcellx, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/15/2023
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/15/2023
Mirum Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2023
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2023
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/7/2023
CVRx, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/5/2023
Arcellx, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/17/2023
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/20/2023
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/4/2023
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/22/2022
Arcellx, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/19/2022
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/2/2022
Akouos, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/19/2022
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/19/2022
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/1/2022
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
MINERVA SURGICAL INC: Statement of changes in beneficial ownership of securities
4
Monday, 6/13/2022
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Thursday, 6/9/2022
CVRx, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/8/2022
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/26/2022
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/13/2022
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/18/2022
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/3/2022
Arcellx, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 1/5/2022
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/27/2021
Metacrine, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/17/2021
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/28/2021
MINERVA SURGICAL INC: Statement of changes in beneficial ownership of securities
3
Thursday, 10/21/2021
MINERVA SURGICAL INC: Initial statement of beneficial ownership of securities
4
Tuesday, 10/19/2021
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/23/2021
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/2/2021
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 7/2/2021
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Thursday, 7/1/2021
CVRx, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/30/2021
Bright Health Group Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/30/2021
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 6/29/2021
CVRx, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/25/2021
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/24/2021
Bright Health Group Inc.: Initial statement of beneficial ownership of securities
3
Wednesday, 6/23/2021
Monte Rosa Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/22/2021
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/15/2021
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/14/2021
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/9/2021
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/22/2021
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/18/2021
Marker Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 3/16/2021
Savara Inc: Initial statement of beneficial ownership of securities
4
Tuesday, 3/16/2021
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/7/2020
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/22/2020
Metacrine, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/15/2020
Metacrine, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 8/14/2020
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/28/2020
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 7/13/2020
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/9/2020
Nkarta, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/1/2020
Akouos, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/1/2020
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
3
Thursday, 6/25/2020
Akouos, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/19/2020
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 6/15/2020
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/10/2020
Oyster Point Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/13/2020
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/5/2020
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/29/2020
Black Diamond Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 1/28/2020
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Thursday, 12/26/2019
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/30/2019
Oyster Point Pharma, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/24/2019
Mirum Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/19/2019
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/17/2019
Mirum Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/3/2019
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/25/2019
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/13/2019
CRISPR Therapeutics AG: Statement of changes in beneficial ownership of securities
4
Monday, 5/13/2019
Trevi Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/9/2019
Regulus Therapeutics Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 5/7/2019
Trevi Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 2/19/2019
GENOCEA BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/18/2018
Marker Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 9/10/2018
Adaptimmune Therapeutics PLC: Statement of changes in beneficial ownership of securities
3
Tuesday, 7/17/2018
GENOCEA BIOSCIENCES, INC.: Initial statement of beneficial ownership of securities
3
Tuesday, 7/17/2018
Arsanis, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 7/17/2018
Regulus Therapeutics Inc.: Initial statement of beneficial ownership of securities